Results from the company’s Phase II trial also saw PL8177 elicit a clinical response in 77% of ulcerative colitis patients.

Verona Pharma (VRNA) has amended its existing strategic financing agreements by repaying the revenue interest purchase and sale agreement and ...

Capital, Aurora Capital and Platinum Equity are among the PE firms investing in the pharma packaging and storage services ...

New Leadership and Focus on Advancement of IkT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial ...

US-based biopharmaceutical company KalVista Pharmaceuticals has finished enrolling subjects in its KONFIDENT-KID trial of ...

Bradley Radoff and Michael Torok, who collectively own approximately 5.4% of the outstanding stock of Atea Pharmaceuticals (AVIR) announced ...

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face ...

After every meal, the intestines perform an action called peristalsis - moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.

Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.

A Boogie Wit Da Hoodie will return to Connecticut for an intimate performance at Bridgeport's Foolproof Brewing Company in ...

Research in mice identifies protein responsible for regulating gut movement in response to pressure, exercise, and ...